Announcements Trials

Browse Landscape

Phase

Phase 3 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 18 Carcinoma, Non-Small-Cell Lung 5 Urinary Bladder Neoplasms 3 Nasopharyngeal Carcinoma 3 Recurrence 2 Non-Muscle Invasive Bladder Neoplasms 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Uterine Neoplasms 1 Thromboembolism 1 Stomach Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Malnutrition 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Locally Advanced Pancreatic Cancer 1 Infiltrating Bladder Urothelial Carcinoma 1 Immunoblastic Lymphadenopathy 1 Hypoxia 1 Gallbladder Neoplasms 1 Cholangiocarcinoma 1

Interventions

sugemalimab 1 spartalizumab 1 Vinorelbine 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Liquid Biopsy 1 Gemcitabine 1 Gefitinib 1 Erlotinib Hydrochloride 1 Drug Therapy 1 Docetaxel 1 Cryotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × NSCLC × Gemcitabine × Clear all

NCT06576635 2026-01-20

LUNG-05

University of Illinois at Chicago

Phase NA Recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡